
Merck KGaA
Darmstadt Science and technology group; its M Ventures Arm backed T-Therapeutics in 2026.
Last refreshed: 14 November 2026 · Appears in 1 active topic
Why is Germany's Merck buying into British biotech through M Ventures?
Timeline for Merck KGaA
Mentioned in: T-Therapeutics raises $133m in Series B
UK Startups and InnovationBackground
Merck KGaA, the German Science and technology group based in Darmstadt, joined a British biotech register in November 2026 through M Ventures, its corporate venture Arm. M Ventures joined T-Therapeutics' $133m Series B, co-led by Advent Life Sciences and the British Business Bank.
Founded in 1668, Merck KGaA works in healthcare, life Science and electronics. It is a separate company from the American drugmaker Merck & Co., which trades as MSD outside the United States and Canada.
The venture Arm gives the group an early view of new drug classes, such as T-cell receptor bispecifics, without setting the price of a round.
Is Merck KGaA the same as Merck & Co.?
Which British biotechs has Merck KGaA invested in?
What does Merck KGaA do?
Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Updated 14 November 2026. Editorial standards.